K S Kendler1, H Ohlsson, K Sundquist, J Sundquist. 1. Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA 23298-0126, USA. kendler@vcu.edu
Abstract
BACKGROUND: Drug abuse (DA) is a clinically heterogeneous syndrome. Using medical, legal, death and pharmacy records covering the entire population of Sweden, could we uncover meaningful subtypes of DA? METHOD: We performed a latent class analysis (LCA) on all individuals in Sweden born 1950–1993 who were registered with DA or its consequences (n=192,501) and then validated these classes using demographics, patterns of co-morbidity with alcohol use disorder (AUD), non-DA crime and psychiatric illness, and the pattern of aggregation and co-aggregation in sibling pairs. RESULTS: The best-fit LCA had six classes : (1) low-frequency pure criminal, (2) high-frequency medical criminal, (3) low-frequency pure medical, (4) high-frequency medical, (5) prescription and (6) death. Each class had a distinct pattern of demographic features and co-morbidity and aggregated within sibling pairs with at least moderate specificity. For example, class 2 was characterized by early age at registration, low educational attainment, high male preponderance, high rates of AUDs, strong resemblance within sibling pairs [odds ratio (OR) 12.6] and crime and the highest risk for DA in siblings (20.0%). By contrast, class 5 had a female preponderance, late age at registration, low rates of crime and AUDs, high rates of psychiatric illness, high familiality within sibling pairs (OR 14.7) but the lowest observed risk for DA in siblings (8.9%). CONCLUSIONS: DA as assessed by public records is a heterogeneous syndrome. Familial factors contribute substantially to this heterogeneity. Advances in our understanding of etiological processes leading to DA will be aided by a consideration of this heterogeneity.
BACKGROUND:Drug abuse (DA) is a clinically heterogeneous syndrome. Using medical, legal, death and pharmacy records covering the entire population of Sweden, could we uncover meaningful subtypes of DA? METHOD: We performed a latent class analysis (LCA) on all individuals in Sweden born 1950–1993 who were registered with DA or its consequences (n=192,501) and then validated these classes using demographics, patterns of co-morbidity with alcohol use disorder (AUD), non-DA crime and psychiatric illness, and the pattern of aggregation and co-aggregation in sibling pairs. RESULTS: The best-fit LCA had six classes : (1) low-frequency pure criminal, (2) high-frequency medical criminal, (3) low-frequency pure medical, (4) high-frequency medical, (5) prescription and (6) death. Each class had a distinct pattern of demographic features and co-morbidity and aggregated within sibling pairs with at least moderate specificity. For example, class 2 was characterized by early age at registration, low educational attainment, high male preponderance, high rates of AUDs, strong resemblance within sibling pairs [odds ratio (OR) 12.6] and crime and the highest risk for DA in siblings (20.0%). By contrast, class 5 had a female preponderance, late age at registration, low rates of crime and AUDs, high rates of psychiatric illness, high familiality within sibling pairs (OR 14.7) but the lowest observed risk for DA in siblings (8.9%). CONCLUSIONS: DA as assessed by public records is a heterogeneous syndrome. Familial factors contribute substantially to this heterogeneity. Advances in our understanding of etiological processes leading to DA will be aided by a consideration of this heterogeneity.
Authors: Michael T Lynskey; Arpana Agrawal; Kathleen K Bucholz; Elliot C Nelson; Pamela A F Madden; Alexandre A Todorov; Julia D Grant; Nicholas G Martin; Andrew C Heath Journal: Twin Res Hum Genet Date: 2006-08 Impact factor: 1.587
Authors: Arpana Agrawal; Michael T Lynskey; Pamela A F Madden; Kathleen K Bucholz; Andrew C Heath Journal: Addiction Date: 2007-01 Impact factor: 6.526
Authors: M T Tsuang; M J Lyons; S A Eisen; J Goldberg; W True; N Lin; J M Meyer; R Toomey; S V Faraone; L Eaves Journal: Am J Med Genet Date: 1996-09-20
Authors: M T Lynskey; A C Heath; E C Nelson; K K Bucholz; P A F Madden; W S Slutske; D J Statham; N G Martin Journal: Psychol Med Date: 2002-02 Impact factor: 7.723
Authors: João Mauricio Castaldelli-Maia; Camila M Silveira; Erica R Siu; Yuan-Pang Wang; Igor A Milhorança; Clóvis Alexandrino-Silva; Guilherme Borges; Maria C Viana; Arthur G Andrade; Laura H Andrade; Silvia S Martins Journal: Drug Alcohol Depend Date: 2014-01-03 Impact factor: 4.492
Authors: Giuseppe N Giordano; Henrik Ohlsson; Kenneth S Kendler; Kristina Sundquist; Jan Sundquist Journal: Addiction Date: 2014-07 Impact factor: 6.526
Authors: João Mauricio Castaldelli-Maia; Laura H Andrade; Katherine M Keyes; Magdalena Cerdá; Daniel J Pilowsky; Silvia S Martins Journal: J Psychiatr Res Date: 2016-05-24 Impact factor: 4.791